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ABSTRACT 
AL SHAMARI, SAHAR,  Masters of Science  
June: 2017, Public Health 
Title: The Effect of Protein Supplementation on Body Muscle Mass and Fat Mass in 
Qataris Post-Bariatric Surgery: A Randomized Controlled Trial (RCT) 
Supervisor of Thesis: Fahad, Hanna 
 
Background and objectives: Obesity is a chronic medical condition characterized by an 
accumulation of excess fat in the body that may lead to negative health consequences. 
Losing weight may be achieved via dietary and lifestyle modification; however, surgical 
options are also available with applicable criteria. Bariatric surgery (BS) has been shown 
to be the most effective type of interventions to achieve and sustain significant weight 
loss in morbidly obese people. One of the most common post-bariatric surgery 
complications of is protein malnutrition and micronutrients deficiency.  The objective of 
the present study is to examine the effectiveness of protein supplementation in reducing 
the risk of developing protein malnutrition that lead to low muscle mass and low protein 
level, in post-bariatric surgery patients. 
 
Methodology: This study is a double-blinded randomized control trial both investigators 
and participants were blinded to the treatment. Recruitment of participants began in 
March 2017 following the ethical approval of the trial (HMC IRB approval no. 
16433/16). The intervention group will receive protein supplement which contain 20 g of 
protein and the placebo group will receive zero protein supplement every day and all 
participants were followed for 1 month post-surgery. The randomization was done on a 
weekly basis within blocks of 8 or 10 patients. Independent Sample-T Test and Paired 
Sample-T Test were performed to measure the effect of the intervention and the control 
on the study group.  
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Results: The mean weight loss in the control group was 9.6 kg, while the intervention 
group mean weight loss was 10.7 kg, with the difference between the 2 groups being 
statistically significant (p= 0.03). Change in muscle mass percentage was +0.50% in the 
placebo group, and +2.3% in the intervention group, with a P value of the difference of 
0.149. Fat percentage change in the placebo group was -1.6% and -2.6% in the 
intervention group, with a p value of a difference of 0.153. The percentage change in 
Albumin in the placebo group was 2.76% and 9.71% in the intervention group, with a p 
value of a difference of 0.031. 
 
Conclusion: Our study has confirmed findings from multiple studies that protein 
supplementation in patients post-bariatric surgery is a successful intervention for healthy 
and balanced weight loss. We have also found after 1 month of follow up that patients 
who took the treatment displayed higher level of serum albumin than those who took 
dietary advice alone. We have also shown trends towards significance in results of 
muscle and fat % change between the 2 groups and a larger sample size and a longer 
follow-up may further signify these results. This confirms that surgery alone cannot put 
an end to obesity and must be combined with well-structured nutritional education so 
patients do not go back to their old habits and put the weight back on.  
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1. INTRODUCTION 
Obesity is a chronic medical condition characterized by an accumulation of 
excess fat in the body that may lead to negative health consequences. It is the major 
contributor to some of the most prevalent chronic conditions, such as type 2 diabetes 
(T2D), heart and kidney diseases, metabolic syndrome, sleep apnea, and depression 
(National Institutes of Health (NIH), 2013; Ogden, Yanovski, Carroll, & Flegal, 2007). 
Obesity is the fifth leading risk factor for deaths globally, making it an extremely 
important public health issue (Ogden, Yanovski, Carroll, & Flegal, 2007). In 2014, a 
World Health Organization (WHO) report showed that more than 1.9 billion adults aged 
18 years and older were overweight with over 600 million being obese (see Figure 1 for 
obesity classification). In addition, 44% of the diabetes burden, 23% of heart disease 
burden, and 7–41% of certain cancer burdens are associated with overweight and obesity 
(WHO, 2015). Around 2.8 million people die each year as a result of being overweight or 
obese. The majority of these deaths is premature and preventable and may apply an 
economic burden on the health systems (Reilly and Kelly, 2011).  
Attempts to reverse obesity through weight loss have been the focus of the 
attention of many, including researchers, scientists and clinicians. This has been chiefly 
achieved via dietary and lifestyle modification as well as surgical approaches. Bariatric 
surgery (BS) has been shown to be the most effective type of approach to achieve and 
sustain significant weight loss in morbidly obese people (Sjöström et al., 2007). Bariatric 
surgery is defined as a group of surgical procedures performed to facilitate substantial 
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weight loss by reducing the size of the stomach and/or limiting absorption in the small 
intestine(American Society for Metabolic and Bariatric Surgery (ASMBS), 2017). It is 
considered a highly efficacious treatment for extreme obesity. However, bariatric surgery 
patients frequently report difficulty initiating and maintaining healthy behavioral changes 
following surgery (Elkins et al., 2005). Most Post-bariatric surgery patients are strictly 
placed on liquid diet during the early post-operative phase and are practically unable to 
consume large quantities of food in one sitting or taking solid protein within the first 
months, which put them at higher risk of developing protein malnutrition (Richardson, 
Plaisance, Periou, Buquoi, & Tillery, 2009). 
Post-surgery multivitamin and high protein supplementation is important to avoid 
any nutrient deficiency (Damms-Machado et al., 2012). High protein supplements are 
mainly rich in protein and supplemented with vitamins and minerals. These supplements 
in general are inexpensive, widely distributed, and commonly used by people or patients 
who need nutritional supplementation while recovering from an illness or post-surgery 
especially post-bariatric surgery (Damms-Machado et al., 2012). 
Protein supplementation is an effective approach to ensuring that post-bariatric 
surgery patients maintain muscle mass and healthy levels of the above-mentioned 
nutrients and body compositions. In the absence of this, the weight loss achieved by the 
surgery may present a systematic issue leading to higher fat percentage and lack of these 
important elements that are essential for the function of the human physiology. The 
imbalance of such essential body compositions and nutrient can also lead to pathological 
  
   
3 
 
and irreversible conditions. The objective of the present study is to examine the 
effectiveness of protein supplementation in reducing the risk of developing protein 
malnutrition that lead to low muscle mass and low protein level, in post-bariatric surgery 
patients. 
 
 
Figure 1. World Health Organization Body Mass Index (BMI) classification for adults 
(Adopted from WHO Global Database on Body Mass Index, 2016) 
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2. LITERATURE REVIEW 
 
2.1 Bariatric surgery indications and effectiveness 
 The general benefits of bariatric surgery are significant weight loss, reduced 
depression and anxiety, improved quality of life, and reduced mortality in patients 
through controlling comorbidities.  
 Bariatric surgery is an effective treatment for obesity, provides a long term of 
weight loss control, and improves obesity-related comorbid conditions (Madura & 
DiBaise, 2012; Nielsen et al., 2014). The main purpose of bariatric surgery is to reduce 
overall mortality and resolution or marked improvement of debilitating chronic 
conditions such as hypertension, diabetes, hyperlipidemia, obstructive sleep apnea, and 
obesity - thereby prolonging life expectancy and improving quality of life (Arterburn & 
Courcoulas, 2014). 
 Bariatric surgery is a group of procedures, which facilitate weight loss by 
reducing the food consumption of an individual after surgery. Three main bariatric 
surgery procedures include gastric bypass, gastric banding and sleeve gastrectomy. 
According to American Society for Metabolic and Bariatric Surgery (ASMBS) (2017), 
gastric bypass is the most common. It involves re-routing of digestive system past the 
stomach to enhance satiety.  For gastric band procedure, an inflatable band is placed on 
the top of the stomach to create a small stomach pouch which restricts the amount of food 
that can be eaten and reduces feelings of hunger by pressing on the surface of the 
  
   
5 
 
stomach. Sleeve gastrectomy removes 80% of the stomach to create a small stomach 
pouch, which also reduces food consumption (Whiteman, 2013). (Figure 2. Types of 
bariatric surgery) 
 
 
Figure 2. The 3 main types of bariatric surgery used to reduce obesity  
(Adopted from Bariatric Surgery and the Endocrine System Fact Sheet by Morton and 
Salehi, 2012) 
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 Based on the National Institute for Health and Excellence (NICE) guideline 
published in 2006, bariatric surgery is recommended as a treatment option for people 
with morbid obesity: if they have a BMI of 40 kg/m2 or more, or between 35 kg/m2 and 
40 kg/m2 and other comorbidities such as type 2 diabetes or high blood pressure that 
could be improved if they lost weight; all appropriate non-surgical measures have been 
unsuccessful; and should be a part of a comprehensive package provided by a specialist 
team. It is also recommended as a first-line option for adults with a BMI of more than 50 
kg/m2 in whom surgical intervention is deemed appropriate (NHS NOO, 2010). 
 Bariatric surgery procedures have shown greater improvements in terms of weight 
loss outcomes with lesser occurrences of weight comorbidities regardless of the type of 
procedure when compared to non-surgical interventions. This was based on a twenty-two 
trials done with 1798 participants included followed up from one to two years for 
measures of weight change after surgery.  Improvements for some aspects of health-
related quality of life, such as physical activity and healthy behavior, were noted 
(Colquitt, Pickett, Loveman, and Frampton, 2014). 
 Studies show significant decrease in weight and hemoglobin A1c (HbA1C) at 2 
years in patients with T2D previously treated with BS, showing good gastrointestinal 
tolerance (Gorgojo-Martínez, Feo-Ortega, & Serrano-Moreno, n.d.). Also Bariatric 
surgery can lead to a modest reduction in clinical depression over the first post-operative 
years (Luppino et al., 2010). Systematic reviews and meta-analyses of the effectiveness 
and risks of bariatric surgery showed a profound reduction in weight with low mortality 
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outcomes associated with surgery (Colquitt, Pickett, Loveman, and Frampton, 
2014;Arterburn& Courcoulas, 2014). Although mortality rates for post-bariatric surgery 
patients have decreased significantly and are now similar to those of cholecystectomy or 
appendectomy in bariatric centers with high surgical volumes, however, the early and late 
rates of adverse events associated with bariatric surgery are still problematically high at 
17% (Chang et al., 2014).  
 With bariatric surgery’s exceptionally low mortality rate, it was considered 
remarkable because more lives were improved considering the life-threatening effects of 
obesity on patients before the surgery. Thus, the benefits brought by bariatric surgery to 
its patients exceeded the risks (American Society for Metabolic and Bariatric Surgery 
(ASMBS), 2017). Studies showed at least 90 percent of people with severe obesity who 
undergone bariatric surgery have been successfully maintaining at least 50 percent body 
weight loss after surgery, and more than 80 percent of those with very severe obesity 
managed maintain at least 50 percent excess body weight loss (Schollenberger, 2016). 
Effect of bariatric surgery not only improved health and longevity but also the quality of 
life of the individual. It has positively enhanced the individual’s self-esteem, social 
interactions, work and sex drive, and has reduced depression and anxiety (ASMBS, 
2017). 
Obesity is one of the greatest health problems in Qatar. More than 70% of Qatar 
population is either obese or overweight and nearly half of all men are obese (Qatar 
Biobank Annual Report, 2016). Bariatric surgery service has started at HMC in 2011 to 
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meet the growing demand for weight loss surgery due to obesity is endemic in Qatar.  
In February 2011, HMC took the decision to recognize Bariatric Surgery as an 
independent service. This was done for a number of reasons and mainly amongst the 
reasons are: 1) to improve the care patients receive at HMC and to bring it to the highest 
international standards, 2) to deal with the obesity endemic in Qatar.  
Following the guidelines from Supreme Council of Heath Qatar, the national 
bariatric guidelines indications for surgery are as follows: 
1, Patients with a BMI >40 kg/m2 without coexisting medical problems and for 
whom bariatric surgery will not be associated with high risk. 
2, Patients with BMI ≥35 kg/m2 and one or more severe obesity related co-
morbidities. 
3. Patients with BMI of 30-34.9 kg/m2 with uncontrolled type 2 diabetes or 
metabolic syndrome may also be offered a bariatric procedure if approved by 
multidisciplinary team decision (Qatar National Bariatric Guidelines Supreme Council of 
Heath Qatar,  2016) (Appendix D).  
 
2.2 Post-bariatric complications 
Whatever the bariatric procedure, there is a need for routine nutritional screening, 
recommendations for appropriate supplements and monitoring compliance (Ziegler, 
Sirveaux, Brunaud, Reibel, and Quilliot, 2009). For the three most common procedures, 
including adjustable gastric bands (AGB), sleeve gastrostomy (SG) and roux-en-Y gastric 
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bypass (GBP), iron deficiency is common especially in menstruating women mainly as a 
consequence of nutrient deficiencies (Jáuregui-Lobera, 2013). GBP, for instance, is 
associated with greater deficiency risks from calcium, vitamin D and vitamin B12, in 
comparison with other types of bariatric surgeries. Being deficient in vitamins and 
minerals leads to serious complications such as encephalopathy or protein-energy 
malnutrition (Ziegler, Sirveaux, Brunaud, Reibel, and Quilliot, 2009).  
Gastric bypass surgery makes stomachs smaller and it changes the way body 
handles the food taken. Because one eats less food, the body cannot absorb all the 
calories from the food eaten and it misses on the absorption of some important vitamins 
and minerals. Thus, it is recommended to take vitamins and minerals to support the 
body’s optimal well-being.   
Bariatric surgery complications may develop if the patients do not follow the 
instruction of taking medication or supplement. After surgery the incidence of vomiting, 
nausea or different food intolerances may further increase the risk of post-surgery 
complications (Karmali et al., 2010; Moize et al., 2003). Unfortunately, patient 
deficiencies result from inadequate calorie or food intake that is associated with macro 
and micro nutrient mal-absorption.  
One of the common post-operative deficiencies or complications of bariatric 
surgery is protein malnutrition caused by inadequate protein intake. Protein is the most 
important nutrient in the post-bariatric diet. Studies show that it plays a significant role in 
body weight regulation (Griffith, Birch, Sharma, and Karmali, 2012). These kinds of 
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surgeries work to restrict energy intake mainly to reduce body weight but on other side it 
may lead to insufficient protein intake, protein absorption, and excess loss of lean tissue 
(Moize et al., 2003). Nutrition supervision is one of the very important sides for post-
bariatric patients because it may lead to many predicaments such as malnutrition, 
vitamin, micro- and macronutrient deficiencies that can lead to deleterious consequences 
(Damms-Machado et al., 2012; Friedrich et al., 2013). 
Laparoscopic Roux-en-Y gastric bypass (LRYGB), which is a standard bariatric 
surgical procedure, presents excellent long-term results, but it is also associated with 
clinically late complications, which develop over the long term in post-operative bariatric 
patients. These include weight gain and nutritional deficiencies (Griffith, Birch, Sharma, 
and Karmali, 2012). After the bariatric surgery procedure, weight gain occurring about 
10% of patients after 5 years and in about 20% of patients after 10 years (Christou, Look, 
and Maclean, 2006), the cause of which maybe multifactorial such as “lack of control 
over food urges, addictive behaviors, decreased overall postoperative well-being, lack of 
self-monitoring and fewer postoperative follow-up visits“(Odom, Zalesin, Washington, et 
al., 2010). Moreover, nutritional problems after bariatric surgery occur due to decreased 
food intake or low physical activity, reconfiguration of GI motility and enzymatic 
changes. Other complications that arise are anemia, which is estimated to occur in 20%-
49% of patients after surgery due to iron, folate and vitamin B12 deficiencies (Lopez, 
Patel, and Koche, 2007).   They are likewise deficient in magnesium, zinc, calcium, 25-
hydroxyvitamin D, thiamine and β-carotene (Lopez, Patel, and Koche, 2007; Toh et al., 
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2009; Dalcanale, Oliveira, Faintuch, et al., 2010). 
According to Misuari Bariatric Services (2016), zinc deficiency has been reported 
in 36% of gastric bypass patients while magnesium deficiency is rare. Zinc, as  an 
antioxidant nutrient necessary for protein synthesis, is recommended for gastric bypass 
patients to take a multivitamin with 100% of the daily value for zinc or 40 to 60 mg of 
zinc twice a day for once month should deficiency develop ed. For magnesium intake, 
gastric bypass patients should take up to 300 mg of magnesium per day to correct 
deficiency.  
2.3 Importance of protein post-surgery 
The major macronutrient deficiency after bariatric surgery is protein malnutrition 
(Bal et al., 2012).Strategies for successful weight loss or weight reduction after bariatric 
surgery is the purpose of reducing body fat mass (FM) while minimizing reductions in 
lean tissue mass (LTM) which is significant for body health status (Friedrich et al., 2013). 
A protein-rich diet make a person feel satiated, and thereby the consumption will be low 
in overall energy intake (Westerterp-Plantenga, Nieuwenhuizen, Tomé, Soenen, & 
Westerterp, 2009). 
Post-bariatric medical guidelines for the nutritional support recommend an 
average daily protein intake (PI) of 60-80 g or 1.1 g/kg of ideal body weight (IBW) after 
surgery to reduce an undesirable post-surgical excessive loss of LTM(Mechanick et al., 
2009; Snyder-Marlow, Taylor, & Lenhard, 2010). Continuing the proper daily intake of 
protein can be challenging for post-bariatric patients, as explained above. Subsequently, 
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reduction in blood protein levels, and finally in muscle mass has to be expected(DeLegge 
& Drake, 2007). As previously mentioned, micronutrient deficiencies are common in 
obese patients, and can occur in both the pre and post-operative settings(Shankar, Boylan, 
& Sriram, 2010). 
2.4 Optimal post-bariatric surgery care 
In post-bariatric surgery diet, protein is a cornerstone because it serves as the 
building block of muscles. It becomes very important during post-bariatric surgery 
because proteins are constantly being broken down and needed to be replaced 
continuously. Being deficient in protein lacks the necessary body nutrient to rebuild 
muscle, which is important in having good health and weight loss (Rogers, 2016).  
According to American Society for Metabolic and Bariatric Surgery (ASMBS, 
2017), bariatric surgery can give long-term positive health and weight loss outcomes 
when given good aftercare and observe good lifestyle. ASMBS (2017)has specific 
recommended doses, such as having at least 64oz of fluids a day to prevent dehydration, 
constipation and kidneys stones. Daily supplements are also required such as multi-
vitamins, vitamin D, calcium, iron and vitamin B12. Moreover, patients who undergone 
bariatric surgery are advised to take protein-rich foods, with 60-100g daily depending on 
the medical conditions, operation type and level of activity. It is likewise advised to limit 
consumption of carbohydrates up to 50 grams per day to avoid weight regain.  
Many studies indicate a significant reduction in lean body mass and decrease in 
levels of albumin and pre albumin resulting from protein deficiency after bariatric 
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surgery. Adequate protein in the patient diet is important as it is the main reason the 
influences body composition after surgery and also, minimizes the occurrence of losing 
muscle mass (Damms-Machado et al., 2012; DeLegge & Drake, 2007; Moize et al., 
2003). 
 
2.5 Needs for protein supplement 
Protein supplement is important for patients who have undertaken bariatric 
surgery. The mechanism why patients do better with high protein supplement are 
somewhat unclear and is likely to be multifactorial, with several components of the 
supplement contributing to better effects (Arterburn & Courcoulas, 2014). It might 
facilitate weight loss, especially body fat loss, and work against muscle mass wasting 
(Lejeune, Kovacs, & Westerterp-Plantenga, 2005). After bariatric surgery, long-term 
follow-up focuses mainly on weight loss maintenance, blood value and adherence to 
aftercare recommendations regarding micronutrient supplementation (Elkins et al., 2005). 
For all post-bariatric patients remedial measures should be undertaken before any 
significant lean body mass loss occurs. It is important that dietary sources of protein are 
the first food choice for post-bariatric patients. Oral intake (high protein sources) and a 
high-protein formula or supplement as the first step must be encouraged to increase 
protein level intake. If the patient cannot take high protein food, he/she will be taking the 
protein supplements. This is often difficult in obese patients who are trying to lose weight 
especially in first stages of diet when they can't tolerate meat products(Schweiger, Weiss, 
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& Keidar, 2010).  
Weight loss that occurs from losing muscle instead of fat will happen for post-
surgery patients and that is considered undesirable outcome. Subjects need to work 
against developing chronic protein deficiency. If it is not possible for them to meet 
protein requirements through diet then protein supplements should be considered 
(Thorell, 2011).  
High energy levels from dietary protein restrict increase in body weight through 
its satiety and energy inefficiency related to the change in body composition. In the short 
term, protein is more satiating than carbohydrate. An increase in protein consumption 
significantly lowers body weight regain after weight loss. The positive effect of high-
protein diets on body weight loss was evident only under ad-libitum energy intake 
conditions (Westerterp-Plantenga, 2003).  However, the consumption of protein greater 
than two to three times the U.S. Recommended Daily Allowance contributes to urinary 
calcium loss and may, in the long term, predispose to bone loss. Caution with these diets 
is recommended in those individuals who may be predisposed to nephrolithiasis or 
kidney disease, and particularly in those with diabetes mellitus (Eisenstein, Roberts, 
Dallal and Saltzman, 2002). A high protein diet shows a reduced energy efficiency 
related to the body-composition of the body-weight regained which favors fat free mass 
(Western-Plantenga, 2008).  
Protein-induced diets having all essential amino acids exhibit higher increases in 
energy expenditure than low-protein diets. Both in young and elderly adults, there was no 
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adverse effects observed on net bone or calcium balance in consuming protein-induced 
diets. Protein-rich diet is particularly helpful to individuals with obesity and metabolic 
problems and with type 2 diabetes (Westerterp-Plantenga, Nieuwenhuizen, Tome, 
Soenen, and Westerterp, 2009). Low-carbohydrate or high-protein diets are beneficial for 
weight loss, increased satiety and better metabolic parameters (Kushner and Doerfler, 
2008) 
A diet with low-glycaemic index-low-fat-high-protein has unique beneficial 
effects compared with the conventional American Heart Association (AHA) diet for the 
treatment of the atherogenic metabolic risk profile of abdominally obese patients, as 
shown by the favorable changes in the metabolic risk profile noted such as decreases in 
triacyglycerols, lack of increase in cholesterol. High-density lipoproteins (HDL)-
cholesterol ratio, increase in low-density lipoprotein (LDL) particle size (Dumesnil et al., 
2001).  
Evidence suggests that meals with higher protein content increase the chance of 
weight loss and fat loss as compared to low-protein diet. In dietary practice, it is 
recommended to partially replace refined carbohydrate with protein sources which 
contains lower saturated fat (Halton and Hu, 2004). 
The importance of protein supplementation in bariatric patients was underscored 
as it was found to be effective in achieving the recommended daily protein intake among 
bariatric patients. With 101 patients undergoing laparoscopic gastric bypass (LGBP) or 
laparoscopic sleeve gastrostomy (LSG), weight loss and male gender had significant 
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association with loss of fat free mass (p < 0.001) (Andreu, Moize, Rodriguez, Flores and 
Vidal, 2010).  
Patients who undergone bariatric surgery need to adhere to a special dietary 
recommendation to achieve weight loss goals and maintenance. Literature reviews 
conducted showed postoperative consumption of protein being linked to induction of 
satiety, weight loss and nutritional status. A protein-rich diet can help increase satiety, 
enhance weight loss, and improve body composition (Faria, Faria, Buffngton, de Almeida 
Cardeil, Ito, 2011).  
The role of protein in weight management was highlighted by Noakes (2008). 
Studies on a higher protein pattern have shown improvements in body composition 
despite similar weight loss.  Protein intake and exercise were associated with improved 
lean mass retention. Enhanced satiety, as an important factor in weight loss, studies 
revealed that high protein meals and foods are more satiating than high carbohydrate or 
high fat meals based on some sensory ratings done (Noakes, 2008). 
Since post-operative bariatric patients are at risk of protein deficiency, a study to 
determine possible benefits of postoperative protein supplementation weight reduction, 
body composition, and protein status was conducted by Schollenberger et al. (2016). 
Twenty obese patients who underwent bariatric surgery were randomly assigned to a 
daily protein supplement over 6 months and to the control group given with isocaloric 
placebo in a double-blind fashion, where protein intake, energy intake, body weight, body 
composition, blood proteins, and grip force were collected prior to intervention at 1, 3, 
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and 6 months after operation. Results showed that body composition is improved by 
protein supplementation through increased loss of body fat mass and reduced loss of lean 
body mass within the 6 months follow up (Schollenberger et al., 2016). 
 
2.6 Whey and Leucine supplementation 
In a double-blind randomized controlled trial, the effect of a high whey protein 
(leucine) and vitamin D-enriched supplement on muscle mass preservation during 
intentional weight loss in 80 obese older adults showed that appendicular muscle mass 
was preserved than using isocaloric control diet, without significant difference between 
the two groups in terms of  muscle strength and function which improved overtime.  This 
supplementation reduces risk of sarcopenia by preserving lean muscles in the elderly 
(Verreijen et al., 2015). 
A 13-week intervention of leucine-enriched whey protein and vitamin D oral 
nutritional supplement resulted in improvements in muscle mass and lower-extremity 
function among sarcopenic older adults. This proves that nutritional supplementation 
alone could positively improve sarcopenia and prevent mobility disability especially 
among geriatric patients who are unable to exercise (Bauer et al., 2015).  
A meta-analysis conducted related to leucine-rich protein supplementation in the 
geriatric population on its effects on anthropometrical parameters and muscle strength 
showed that leucine supplementation has beneficial effects on body weight, body mass 
index, and lean body mass especially those subjects already prone to sarcopenia. When 
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compared to control groups, leucine supplementation significantly increased gain in body 
weight (p=0.02), lean body mass (p=0.0005), and body mass index (p=0.001). Leucine-
rich protein supplementation was more effective in the participants manifesting 
sarcopenia in terms of body weight and lean body mass (Komar, Schwingshackl and 
Hoffman, 2015). Similarly, leucine supplementation increases the muscle protein 
fractional synthetic rate and therefore is beneficial to age-related decline in muscle mass 
especially in elderly individuals (Xu, Ta, Zhang, Gui, and Yang, 2015).  
Individualized, nutrient-rich diets within current nutritional guidelines for weight 
control can be recommended by medical practitioners. Diets with moderately increased in 
protein and restriction in carbohydrate and fat intake are beneficial on body weight, body 
composition, and associated metabolic parameters. However, long-term compliance and 
safety of chronic high-protein intake should be observed (Brehm and D’Alessio, 2008).  
Utilization of specific protein such as whey protein provides a physiologically 
functional food component for body weight regulation and reduction which contributes to 
regulating food intake by increasing satiation through whey protein fractions, bioactive 
peptides, amino-acids released after digestion, and combined action of whey protein 
and/or peptides and/or amino acids with other milk constituents (Luhovyy, Akhayan, and 
Anderson, 2007).  
Greater weight losses are given by diets high in protein, but either low or modest 
in carbohydrate, than traditional low-fat diets. It is the protein, and not carbohydrate, 
content that is important in promoting short-term weight loss which is an effect from 
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increased satiety.  This evidence indicates that protein should contribute 25% to 30% of 
energy intake, moderate in carbohydrate (35% to 50% of energy) and in fat (25% to 35% 
of energy) (Schoeller and Buchholz, 2005).  
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3. AIM AND OBJECTIVES 
3.1 Aim: 
 The aim of this study is to assess the effectiveness of protein supplementation in 
reducing the risk of developing protein malnutrition that leads to low muscle mass and 
low serum protein level, in post-bariatric surgery patients.  
 
3.2 Objectives: 
The specific objectives of our study are to assess changes in the following health 
parameters at 1 month of the trial: 
1. Muscle and fat mass.  
2. Body Weight. 
3. Protein (Albumin and total protein). 
4. Vitamin B12 
5. Magnesium and Zinc. 
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4. RESEARCH QUESTIONS 
 
1. What is the difference in change of muscle and fat mass between participants who 
received protein supplement and those who received the placebo?  
2. What is the percentage of weight reduction in the intervention in comparison with 
control group?   
3. What is the difference in protein level (albumin/ total protein) in post-bariatric patients 
receiving intervention compared with control group?    
4. What are the changes in Vitamin B12, Magnesium and Zinc in the intervention group in 
comparison with the control group? 
 
 
5. HYPOTHESIS 
 
We hypothesized that post-bariatric surgery patients receiving protein supplement 
will develop the following at the end of the trial (compared with those receiving zero 
protein supplement): 
1. Lower fat mass  
2. Higher muscle mass 
3. Higher percentage of weight reduction  
4. Higher serum protein levels 
5. Higher levels of Vitamin B12, Zinc and Magnesium  
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6. METHOD 
 
6.1 Study design 
This study is a double-blinded randomized control trial. Both investigators and 
participants were blinded to the treatment (intervention and placebo products were 
identical and unlabeled). The research recruited participants in March 2017 and following 
them up for 1 month. The randomization was done on a weekly basis within blocks of 8 
or 10 patients. This was roughly the number of patients available per week.  
In this RCT simple randomization process was used to assign patients to either 
groups- intervention & placebo. Using a computer generated random list, the treatment 
and the placebo were allocated in a random manner to numbers that label individual 
patients. 
Both the intervention and control groups received standard dietary instructions in 
post-bariatric surgery period including hospital stay (1-2 days) and 1 month after. The 
intervention group received protein supplement and the placebo group received zero 
protein supplement everyday over 1 month after surgery. The placebo & the protein 
supplement slightly differed in the caloric (the difference is 150 kcal/bottle) content. 
Although this difference was not clinically significant, this issue was addressed as a 
limitation for this study. 
Investigators and researchers, including providers of care (dietitian and rehab 
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staff) in this study were blinded to the intervention, i.e. they were not aware of who was 
on protein supplement and who was on placebo.  Patients were also blinded to the 
intervention, i.e. they did not know whether they are taking protein or zero protein 
supplement. For the blinding, a dietician did assign the treatment and the control to 
patients as per the above randomization results. This dietitian was also responsible for 
filling the intervention & control ready-to-feed shakes into identical bottles labeled either 
A or B. The dietician did not have any other responsibility such as data entry or follow up 
of participants as this was done by the PI and research team; he was only responsible for 
the blinding process. Un-blinding was unlikely within the settings of our trial, however, 
any suspicion of un-blinding was dealt with appropriately and may result into the 
cessation of participation in the trial. 
 
6.2 Study participants 
The recruitment of participants for this RCT was based at Hamad General 
Hospital. Patients who underwent bariatric surgery and fulfill our inclusion criteria were 
randomized to either the intervention or the control arm of the study. The catchment area 
for Hamad General Hospital can include the entire Doha district and the surrounding 
metropolitan area. However, admission to the hospital may also include other regional 
areas, thereby making the sample of our population representative of the entire Qatari 
population.  
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6.3 Sample size 
The study population was bariatric patients admitted to bariatric department for 
surgery based on their eligibility criteria (BMI≥35). All patients were enrolled in the 
study prior to admission and were then given the intervention or the placebo on the first 
day post-surgery. A total of 42 obese Qatari adults from Bariatric and Metabolic Center 
in Hamad General Hospital (HGH), who fulfill HGH entry criteria for bariatric surgery, 
were enrolled in this experimental study. This was subject to availability and time 
constraint for the purpose of this thesis. However, a statistical advice provided suggested 
that the number obtained is sufficient for the purpose of the trial. 
Using the primary outcome estimates available in the published study 
(Schollenberger, A E et al; 2016); body fat mass (BFM) and lean body mass (LBM) (kg) 
in the intervention group at baseline and 3 months (BFM baseline 78.2±19.1 and 3 
months 59.9±15) and (LBM baseline 65.2±14.2 and 3 months 58.2±10.6) compared with 
Placebo group (BFM baseline 68.2±12.0 and 3 months 53.9±11.5) and (LBM baseline 
68.9±13.4 and 3 months 62.2±11.3) and with 90% power and a type I error rate of 5%, 
the required sample size would be 70 participants (35 in each group), however, to 
compensate for possible dropouts, non-response and loss to follow-up it would be good to 
increase additional 15% to 20% in calculates sample size (a total of 80 participants i.e., 
40 in each group). The only difference between the above study population and the 
population of our RCT is that the German study population was more obese (BMI 
between 49 and 52). Both studies looked at the effect of protein supplementation on 
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muscle and fat mass in post-bariatric surgery patients.  
6.4 Inclusion criteria: 
Study participants had the following criteria in order to participate in the trial: 
1. Qatari males or females. 
2. Aged between 18 and 60 years 
3. Based at the bariatric surgery list of HMC with their follow up scheduled be at 
HMC (see appendices). 
6.5 Exclusion criteria: 
 Patients were excluded from participating in the trial if they have the following criteria: 
1. Any Renal or liver disease because that will affect protein or albumin level in body. 
2. Past history of bariatric surgery (Gastric Band & Gastric bypass) 
3. Patients will be further excluded after starting the trial if they did not take at least 
80% (minimum 24 bottles) of their allocated intervention or placebo products 
throughout the trial. 
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6.6 Study flow chart (Figure 3) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
High protein supp.  
1 month follow up 
Zero Protein Supp.  
1 month follow up 
42eligible post-bariatric patients at 
Intervention group 
21 post-bariatric patients 
Control group 
21 post-bariatric patients 
Randomization 
Eligibility assessment (74) 
32ineligible 
participants 
were excluded  
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6.7 Intervention and control 
6.7.1 Intervention 
1. Patients received nutritional counseling by a bariatric dietitian as a routine standard of 
care, which included strictly fluid diet for the first months. This educational component 
applies to all post-bariatric surgery patients at discharge. (Appendix G). 
2. Before discharge from the hospital, patients were provided with the supplement and 
were advised by the dietitian regarding its use (one can per day, over 3-5 intervals, i.e. the 
bottle will be used over the entire course of the day through a number between 3 and 5 
shots/doses). 
3. Each supplement (bottle) contains 20 g of protein, 250Kacl plus different micronutrient 
and macronutrient, per 200 ml can (Cubitan,Protein, Nutricia, Netherlands), ( appendix 
E). 
 
6.7.2 Control (placebo) 
1. Patients received nutritional counseling by a bariatric dietitian as a routine standard of 
care, which included strictly fluid diet for the first months. This educational component 
applies to all post-bariatric surgery patients at discharge. (Appendix G). 
2. Before discharge from the hospital, patients were provided with the supplement 
(placebo)andwere advised by the dietitian regarding its use (one can per day over 3-5 
intervals). 
3. Following hospital discharge, Control patients received supplement which contains 0g 
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protein, fat free, 100 kcal and enriched with electrolytes, per can (200 ml) (preOp, 
Nutricia, Netherlands), ( appendix F). 
Note: 
a. Both groups were instructed to take one supplement pack through the day in equally 
divided portions, and, they should store it in room temperature and drink it without 
heating. 
b. Giving high protein supplement is an optional routine practice for post bariatric 
surgery patient at HGH, making this practice a predictable approach to our 
participants. 
 
6.8 Materials 
The protein supplement, which is a standard practice, adopted by HMC for post-
bariatric surgery patients, consisted of whey protein isolate with the following 
characteristics:  
• Pure Whey Protein Isolate   
• Whey protein isolate is the most pure and concentrated form of whey protein 
available  
• Whey protein isolate contains higher protein content (90-95%) and less lactose 
(less than 0.5%). It is a complete protein with all the indispensable essential 
amino acids and is an exceptional source of branch chain amino acids (BCAAs), 
especially leucine necessary for tissue growth. Whey protein is a soluble, easy to 
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digest protein and is efficiently absorbed into the body (Marshall, 2004).  
• Aside from amino acids, other biological components of whey protein include 
lactoferin (concentration is commonly 0.35-2.0 percent of total proteins), 
immunoglobulins (10-15 percent of total whey proteins), lactoperoxidase 
(accounts for 0.25-0.5 percent of total protein in whey), glycomacropeptide (with 
10-15 percent), and bovine serum albumin (10-15 percent of total whey protein).  
These bioactive components, the essential and non-essential amino acids help 
improve body mass index especially in individuals doing exercise programs, by 
enhancing muscle mass and reducing fat mass. (Marshall, 2004). 
• It contains (per 200 ml can) 20 g of protein, 250Kacl plus different micronutrient 
and macronutrient. 
• The zero protein supplement contains 0g protein, fat free, 100 kcal and enriched 
with electrolytes, per can (200 ml). 
 
6.9 Measurements 
1. Baseline measurement of body composition (fat mass and muscle mass), height and 
weight were conducted on day one of the trial, using Tanita body composition 
instrument and other physical body measures. 
2. Baseline blood test for total protein, albumin, Vit B12, Zinc and Magnesium levels 
were collected.  
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3. All of the above measurements were repeated at the end of the follow up period (1 
month). 
*Note: all of the above measurements and the collection of blood sample is routine 
practice for post-bariatric surgery patient. 
 
6.10 Study visits 
Patients follow up visit was after 1-month post-surgery at the Bariatric Dietician 
Clinic in OPD department at HGH, and covered the following: 
A. Post-surgery dietary advice, to sustain a hypo caloric and protein-rich diet. 
B. Anthropometric parameters for body composition (see below). 
C. All patients were followed up through weekly phone calls to ensure compliance 
and adherence to the study protocol. Questions such as “how many bottles of 
supplements are left?” Or, “how many bottles have you had so far?” were asked. 
D. Collection of blood sample after an overnight fasting. All blood markers were 
measured and calculated in the central laboratory at HGH. 
E. Patients were asked about their supplement intake compliance to determine their 
eligibility to be part of the study (see exclusion criteria).  
*Note: Collection of blood sample after 1 month is a routine practice for post-bariatric 
surgery patient at HMC 
 
6.11 Body composition (BC) 
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The measurements of anthropometric data took place following overnight fast, 
patients wearing light clothes and barefoot (baseline and 1 month follow up). Tanita's 
body composition analyzer provides precision in estimating body composition including 
Weight, Body Fat Percentage, Body Fat Mass, Body Mass Index (BMI), Fat Free Mass, 
and Estimated Muscle Mass and percentage. However, Height was measured using a 
fixed wall stadiometer, both inter- and intra-reliability testing was conducted prior to the 
trial to ensure consistency of the measures across the study population. The results of 
these tests were satisfactory thereby ensuring that the assessment tools produced 
consistent and reliable measurements.    
 All these data were assessed using TanitaHealthWare software that is specific 
program to analyze body composition. 
 
6.12 Blood sample 
 Blood samples were collected from patients in (HGH) laboratory at baseline and 
1 month following an overnight fast. Complete blood count (CBC) was used. Total 
protein, serum Albumin, zinc, magnesium and vitamin B12 were also assessed. The 
laboratories of HGH are internationally accredited laboratories that follow international 
standards. 
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6.13 Data collection and handling: 
All data obtained from this study were collected by the principal investigator and 
were saved in a secure location where only the project supervisors and a statistician have 
access. Data were de-identified during and post collection to ensure privacy and ethical 
protocols are followed. All data were stored and kept safe for a period of time according 
to HMC policy and remain a property of HMC and the actual physical location of any 
electronic copies was also be at HGH. Confidentiality of patients was highly maintained 
throughout the trial.( appendix C). 
 
7. STATISTICAL ANALYSIS 
Data analyses were performed using the statistical software SPSS package 20. 
The main aim is to analyze Body composition and other anthropometric changes 
throughout follow up. The normality of the variables was assessed by the Kolmogorov-
Smirnov test. Characteristics and demographics of participants were summarized, based 
on the assignment of treatment or placebo, using means and standard deviations (SD) for 
quantitative variables. Baseline data for the two groups were compared using two tailed 
independent samples t-tests. The P value for the difference between the 2 groups for each 
variable was also provided. A baseline analysis of all data for the 2 groups was performed 
using independent t-test with a p-value of the difference. During the follow-up, changes 
in weight, body fat percentage, muscle mass, total protein level, albumin level, vit B12, 
Zinc and Magnesium were compared within groups using paired t-test and between 
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groups using independent sample t-test. A linear regression model was also used to check 
if variables such as age and gender would confound the results. Other fundamental 
confounders such as diet intake were not incorporated into the multivariate binary 
regression model, mainly because post-bariatric patients within the 1st month are both 
unable and not allowed to take any solid foods and few specific liquid foods such as milk 
and soups are recommended to them by the dietician. All patients are trained to follow 
such diet. Moreover, being an RCT, it is expected that all confounders (including hidden 
confounders) are balanced between the 2 groups and no assessment of baseline variables 
such as diet, physical activity and any other biological differences between the 2 groups 
is required. This is consistent with the CONSORT statement for RCTs.  
 
8. ETHICAL CONSIDERATIONS 
The following ethical issues were taken into consideration during the trial: 
1. Patient has the right to refuse participating in the study.  
2. Patient has the right to withdraw from the study in any time. 
3. This was clearly explained to all patients in the “patient consent form” that 
patients were asked to sign as an agreement to enter the study (Appendix A). 
4. Researchers and other health-care professionals held all information about 
patients in strict confidence and disclose it only to those who have a legal right to 
this information. Moreover, the visits were in private rooms to take patients 
measurements. 
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5. Omitting information that might lead to the identification of individual subjects, 
limiting access to the information. 
6. De-identification of data and confidentiality of patients were highly maintained 
throughout the trial 
7. Intervene to protect patients if researchers are highly suspicious that a risk or 
abnormal lab value is imminent, and if sufficient expertise and experience to 
Interpret the situation is not present, staff will seek advice from more experienced 
professionals. 
8. Within the time if there is any significant progression in value or intervention 
group, in this case no need to continue the study. 
 
Ethical approval request was requested from both HMC and QU IRB committees. 
Both committees granted the approval thereby confirming the legitimacy of our study. 
The RCT approval number from HMC is 16433/16(Appendix B) 
Also, we have conducted an RCT to confirm the effectiveness of protein 
supplementation for post-bariatric surgery patients as a means to retain muscle mass so 
retention of protein. Although the protein supplementation is currently used by HMC, it 
is not a standard procedure and requires evidence-based research to help adopting this as 
a standard treatment. This and other ethical issues have been presented to the HMC IRB, 
which has subsequently approved the trial.  
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9. BUDGET 
All supplementation materials were provided by the Department of Bariatric and 
Metabolic Surgery at HGH. The department also provided staff assistance and services. 
Therefore, there is no need to apply for budget for this project. 
 
 
10. CLINICAL TRIAL REGISTERATION  
Our clinical trial was registered with ClinicalTrials.gov (US-NIH) PRS (protocol 
registration and results system) with an ID number: 16433. 
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11. RESULTS 
Baseline results: 
Baseline characteristics and anthropometric data for all participants are 
summarized and presented in Table 1. A total of 74 participants were screened over the 
period of the study recruitment with 32 being ineligible due to inclusion and exclusion 
criteria (inclusion and exclusion criteria sections 6.3 and 6.4). Forty-two participants 
were randomized into either the placebo group or the protein supplementation group 
(treatment) to evaluate changes in weight, body fat percentage, muscle mass, total protein 
level, albumin level, Vit B12, Zinc and Magnesium between baseline and 1 month follow 
up (Figure 1).The majority of participants in the study were females (30 females and 12 
males) with equal numbers of males and females in the 2 groups (15 females and 6 males 
per group).  All individual variables were compared between the 2 groups using an 
independent t-testand no statistically significant differences, apart from BMI, were found 
between the intervention and the placebo groups at baseline (Table 1).  
There was a small but statistically insignificant difference in the mean age of 
participants in the 2 groups [Intervention group: mean age ± (SD) = 33 ±(12.9) and the 
placebo group: mean age ± (SD) = 35.2 ± (9.6), p =0.528]. there was no significant 
difference in height [162.2 ± (9.4) and 162.7 ± (7.8), p= 0.8598], however, participants in 
the intervention group had higher but not statistically significant mean weight in 
comparison with the placebo group [120.7 ± (20.1), vs 109.6 ± (91.3), P ≤ 0.074]. All 
other variables to be assessed in this trial were compared and no significant differences 
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were found between the placebo and the intervention groups (Table 1). 
All variables were assessed for normality at baseline using Kolmogorov-Smirnov test to 
validate the use of linear regression models.  
 
Follow up (1 month) results: 
Change in weight, BMI, muscle and fat mass percentage: 
 Table 2 demonstrates the changes and % changes in weight, fat mass % and 
muscle mass % from baseline to 1 month follow up within the one group (treatment and 
control) and between the 2 groups. The placebo group mean weight loss in the control 
group was 9.6 kg, p ≤ 0.001, while the intervention group mean weight loss was 10.7 kg, 
p ≤ 0.001, with the difference between the 2 groups being statistically significant (p= 
0.03). the BMI was very similar with the placebo group losing 9.5 kg/m2, p ≤0.001, 
while the intervention group BMI loss was 11.6 kg/m2, p ≤0.001 and the difference 
between the 2 groups being statistically significant (p ≤0.001). Change in muscle mass 
percentage in the placebo group has been 1.59, p= 0.676 and 12.78, p≤ 0.001 in the 
intervention group with the difference between the 2 groups not being statistically 
significant (p= 0.149). Fat percentage change in the placebo group was 3.39, p= 0.008 
and 7.74, p≤0.001 with the difference between the 2 groups not being statistically 
different (p= 0.153).  
 
 
  
   
39 
 
Change in total protein and albumin: 
 Table 3 demonstrates the change in the outcome of total protein and 
albuminpercentage at 1 month. The placebo group % change of total protein was 0.88, p= 
0.597 while in the intervention group this was 0.14, p= 0.947 with the difference between 
the 2 groups not being statistically significant (p= 0.620). However, the percentage 
change in Albumin in the placebo group was 2.76, p= 0.185 and in the intervention group 
was 9.71, p≤0.001 with the difference between the 2 groups being statistically significant 
(p= 0.031) 
 
Change in Vitamin B12, Zinc and Magnesium: 
 Table 4 demonstrates the change in the outcome of Vit B12, Zinc and Magnesium 
at 1 month. The placebo group percentage change of Vit B12 was 14.81, p= 0.286 and in 
the intervention group was 11.98, p= 0.339 with the difference between the 2 groups not 
being statistically significant (p= 0.384). For magnesium, the placebo group percentage 
change was 2.5, p= 0.121 and in the intervention group the percentage change was 2.5, 
p= 0.153 with the difference between the 2 groups not being statistically significant (p= 
0.942). For zinc, the percentage change in the placebo group was 4.20, p=0.083 and for 
the intervention group this was 2.4, p= 0.020 with the difference between the 2 groups 
not being statistically significant (p= 0.634) 
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Linear regression model: 
 To ensure that the above effects are not due to confounders, a linear regression 
analysis was performed to test the effect of the intervention on changes in main study 
variables. Table 4 demonstrate the association between weight, muscle mass %, fat mass 
%, Albumin and total protein change in the intervention compared with the placebo, 
adjusted for age and gender. Those in the intervention group had a mean difference of 
2.11 kg of weight loss compared with the placebo with this results being statistically 
significant [95% CI (-3.52, -0.70), P = 0.004]. Both muscle and fat mass % showed 
similar outcome to the paired t-test with percentage gain in muscle mass and percentage 
loss in fat mass, however, similar to the t-test, results were not statistically significant 
[2.96 (-1.55, 7.48), p = 0.19 for muscle mass % and -2.23 (-5.39, 0.94), p = 0.16 for fat 
mass %]. The model for Albumin showed statistically significant association between 
change in albumin level, even after adjusting for age and gender [7.38 (1.41, 13.34), p = 
0.017]. Change in total protein showed no statically significant association with the 
intervention.  
 
Compliance analysis: 
 Table a demonstrates the level of compliance across the 2 study groups. 100% of 
the intervention group consumed at least 80% of their allocated 30 day treatment. 
However, 86% of the control group (18 patients) consumed the minimum required 
amount of 80% of their designated zero protein supplement. 
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Table 1. Demographics and characteristics of study participants at baseline. 
 
Group A: placebo 
(n = 21 ) 
Group B: Intervention 
(n = 21 ) P 
Mean SD Mean SD 
AGE 35.2 9.6 33.0 12.9 0.528 
Gender, n (%)  1.0 
      Male 6 (28.6) 6 (28.6) 
 
      Female 15 (71.4) 15 (71.4) 
HT 162.2 9.4 162.7 7.8 0.859 
WEIGHT 109.6 19.3 120.7 20.1 0.074 
BMI 41.5 5.1 45.7 6.7 0.027 
Muscle Mass % 49.6 8.4 45.4 8.4 0.111 
Fat Mass % 48.4 7.0 51.7 8.7 0.177 
HB 13.0 2.0 12.6 1.5 0.434 
TOTAL_PROTEIN 68.3 5.1 70.0 5.0 0.278 
ALBUMIN 36.2 3.2 34.0 4.3 0.078 
VITAMINB12 270.8 151.4 275.4 120.4 0.913 
MAGNESIUM .8 .1 .8 .1 0.219 
ZINC 11.9 1.2 12.1 .7 0.552 
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Table 2. Change in weight, BMI, fat and muscle mass % from baseline to 1 month follow up. 
 
GROUP A: placebo (n =21) GROUP B: intervention ( n =21 )  
Baseline 1 Month 
Difference 
( % ) 
P value 
(within 
group) 
Baseline 1 Month 
Difference 
( % ) 
P value 
(within 
group) 
P value 
(between 
group) 
M (SD) M (SD)   M (SD) 
WEIGHT 109. 19.3 100 18. -9.60 ˂0.00 120. 20.1 107. 19. -10.69 ˂0.001 0.003 b 
BMI 41.5 5.1 37. 4.8 -9.50 ˂0.00 45.7 6.7 40.6 6.7 -11.16 ˂0.001 ˂0.001b 
Muscle Mass % 49.6 8.4 50.1 12. 0.50 0.676 45.4 8.4 47.7 12. 2.31 ˂0.001 0.149 b 
Fate Mass % 48.4 7.0 46.8 6.5 -1.6 0.008 51.7 8.7 49.1 8.9 -2.62 ˂0.001 0.153 b 
 a paired sample  t-test (change within the same group) . 
 b independent sample  t-test (change between the 2 groups). 
   (-ve values indicate loss at 1 month follow-up while +ve values indicate gain) 
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Table 3. Change in total protein and albumin % between baseline and 1 month follow up. 
 
GROUP A: placebo (n =21) GROUP B: intervention ( n =21 )  
Baseline 1 Month 
Difference 
( % ) 
P value 
(within 
group) 
Baseline 1 Month Differenc
e 
( % ) 
P value 
(within 
group) 
P value 
(between 
group) 
M (SD) M (SD)   M (SD) 
TOTAL_PROTE
IN 
68. 5.1 68. 4.1 0.88 0.597 70.0 5.0 70. 4.9 0.14 0.947 0.620 b 
ALBUMIN 36. 3.2 37. 3.5 2.76 0.185 34.0 4.3 37. 3.5 9.71 0.000 0.031 b 
 a paired sample  t-test  (change within the same group). 
 b independent sample  t-test (change between the 2 groups) . 
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Table 4. Change in vit B12, Magnesium and Zinc % between baseline and 1 month follow up. 
 
GROUP A: placebo (n =21) GROUP B: intervention ( n =21 )  
Baseline 1 Month 
Difference 
( % ) 
P 
value 
(within 
group) 
Baseline 1 Month Differenc
e 
( % ) 
P 
value 
(within 
group) 
P value 
(between 
group) 
M (SD) M (SD)   M (SD) 
HB 13. 2.0 12. 1.7 -3.08 0.123 12.6 1.5 13. 1.2 3.97 0.005 0.002 b 
VITAMINB12 27 151. 31 177 14.81 0.286 275. 120. 30 225. 11.98 0.339 0.384 b 
MAGNESIUM 0.8 0.1 0.7 0.0 -2.50 0.121 0.8 0.1 0.8 0.07 2.50 0.153 0.942 b 
ZINC 11. 1.2 12. 1.6 4.20 0.083 12.1 .7 12. 0.55 2.48 0.020 0.634 b 
 a paired sample  t-test  (change within the same group). 
 b independent sample  t-test (change between the 2 groups) . 
  (-ve values indicate loss at 1 month follow-up while +ve values indicate gain) 
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Table 5. Linear regression model representing the change from baseline to 1 month follow up. 
 
 
 
 
 
 
 
     *model adjusted for age and gender 
 
 
 
  
∆ variables over 1 month  Mean difference  95% CI P value* 
Weight (kg) -2.11 (-3.52, -0.70) 0.004 
Muscle mass % 2.96 (-1.55, 7.48) 0.19 
Fat mass % -2.23 (-5.39, 0.940 0.16 
Albumin  7.38 (1.41, 13.34) 0.017 
Total protein  -0.47 (-4.05, 3.11) 0.79 
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Table a. Compliance data of the groups 
Compliance / Group 
Number of intervention patient 
( high protein supplement) 
Number of control patients 
( zero protein supplement) 
Consumption of more than 80% of supplement ( 24 – 30 bottle) 21 18 
Consumption of more 50 - 80% of supplement ( 15 – 24 bottle) 0 3 
Consumption of 20 - 50 % of supplement ( 6 - 15 bottle) 0 0 
Consumption of less than  20 % of supplement ( 6 – 1 bottle) 0 0 
 
 
 
All 1-month follow up individual parameters including the changes between baseline and follow up are shown below (Figures 
4.a, 4.b, 4.c, ….). 
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Comparison of individual characteristics and demographics between the 2 groups at 
baseline: 
 
 
Figure 4.a. Comparison of change in weight between study groups at 1 month 
 
 
 
Figure 4.b. Comparison of change in BMI between study groups at 1 month 
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Figure 4.c. Comparison of change in muscle percentage between study groups at 1 
month 
 
 
Figure 4.d. Comparison of change in fat % between study groups at 1 month 
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Figure 4.e. Comparison of change in hemoglobin between study groups at 1 month 
 
 
Figure 4.f. Comparison of change in total protein between study groups at baseline 
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Figure 4.g. Comparison of change in albumin between study groups at 1 month 
 
 
Figure 4.h. Comparison of change in vit B12 between study groups at 1 month 
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Figure 4.i. Comparison of change in magnesium between study groups at 1 month 
 
 
Figure 4.j. Comparison of change in zinc between study groups at 1 month 
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12. DISCUSSION 
  
The primary objective of this study was to determine the effect of protein 
supplementation, as a meal replacement, on reducing the risk of developing protein 
malnutrition that lead to low muscle mass and low protein level. The secondary 
objectives of our study were to measure percentage change of muscle mass, fat mass, 
total protein, albumin, Vit B12, Zinc and magnesium levels at 1 month follow up. 
 
Baseline findings: 
To assess whether observed differences are real and genuine and to ensure 
successful randomization, baseline data of study participants were systematically 
compared between the placebo and the treatment groups. No statistically significant 
differences were found between the 2 study groups in relation to any of the above 
parameters, except forthe BMI. The above results confirm the lack of selection bias that, 
if present, may influence the results of the trial.  
 
The CONSORT statement for Randomized clinical trials recommends that baseline 
demographics and clinical characteristics for each group are presented (Altman, 
1996).However, the statement also demonstrates that “significance testing of baseline 
differences in randomized controlled trials (RCTs) should not be performed, because it is 
an excessive measure and can mislead investigators and their readers” (de Boer et al., 
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2015). This study complies with the CONSORT statement in that a simple t-test was 
conducted to compare the means between placebo and treatment groups to ensure no 
significant differences at baseline existed between the 2 groups in relation to the studied 
outcomes. The researchers felt that this step was particularly important for the current 
sample size, where sampling error may be more likely to take place (probability concept).  
Only one statistically significant difference was found between the intervention and 
the placebo groups out of all baseline characteristics we measured. Body Mass Index 
(BMI) was found to be statistically significantly different between placebo and treatment 
groups [(41.5 ± 5.1) for placebo and (45.7 ± 6.7) for the treatment, P value of difference 
= 0.027)]. These findings may indicate that the treatment group was marginally but 
significantly heavier than the placebo group. However, while BMI numbers tell us a lot 
about the health status and particularly about the risk of developing diseases such as heart 
disease and diabetes in an individual and the population, these numbers are somewhat too 
crude to be a useful measure in assessing and analyzing changes in body fat and muscles 
(Casey, 2003). In this study, the impact of protein supplementation on changes of body 
composition and essential substances was assessed. Recently, research studies have 
focused on analyzing fat percentages as an indicator and a more useful measure of 
weight-related diseases than BMI (Gallagher et al., 2000). The most common and 
essential variables used to assess longitudinal analysis in weight loss interventions are 
weight percentage, muscle mass and percentage, fat mass and percentage, while albumin 
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and total protein seem to be the measurements of choice as they provide more accurate 
analysis of the actual changes in accordance to the objectives of this study. The choice of 
variables for the longitudinal analysis in this study is consistent with the majority of these 
recent studies done on weight loss intervention, both surgical and non-surgical 
(Moldovan et al., 2016; Himbert, Ose, Delphan, Ulrich, 2017). In addition, the 
maintenance of muscle mass or fat-free mass has been associated with weight loss 
maintenance (Stiegler & Cunliffe, 2006).  
 
Moreover, the probability of finding one statistically different variable between the 
randomized groups is probably that “chance” that randomization may encounter and 
therefore it is not, considered a failure of randomization. In fact, and as mentioned 
previously, the CONSORT statement cautions researcher against “significant testing” of 
baseline differences in RCTs and clearly states that this should not be performed.  
The target variables were analyzed using Tanita's body composition analyzer. This 
sophisticated analyzer provides objective measures of body composition including 
Weight, Body Fat Percentage and Body Fat Mass. A large number of recent trials and 
weight loss studies have used Tanita’s body composition analyzer (Li et al., 2013; Shim 
et al., 2014). The choice of Tanita is primarily based on the high level of technology the 
analyzer uses to accurately monitor and assess body composition utilizing the latest 
advanced bioelectrical impudence analysis technology that has been developed over the 
last 25 years. The technology is particularly accurate in detecting changes in body 
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composition due to adopting fitness program or undergoing a weight loss intervention 
(Verney et al., 2015; Gába et al., 2015; Beeson et al., 2010;Boneva-Asiova&Boyanov, 
2008). 
 
One month follow up: 
Our study showed that a month after the surgery, there has been an observed 
difference between the 2 groups in weight loss (kg), BMI, muscle mass percentage 
change, fat percentage change and Albumin percentage change. All other parameters 
(Total protein, Vit B12, Magnesium and Zinc) did not show any significant, or even a 
trend towards significant, difference between the 2 groups.   
Protein supplementation was able to induce greater weight loss, muscle mass 
percentage gain and fat mass percentage loss than the dietary advice alone, only a month 
after the bariatric surgery done on all participants. Although only the weight loss results 
were statistically significant (mean weight loss of 10.69kg, p= 0.003), both muscle mass 
% gain and fat mass % loss showed trends towards statistical significance (12.78%, p= 
0.149 and -7.74%, p= 0.153, respectively).  Our findings are consistent with studies that 
investigated the impact of protein supplementations, and those that looked at the effect of 
high content protein meal-replacement programs, on changes in body compositions. A 
number of studies have shown the effectiveness of protein supplementation on the 
reduction of weight in post-bariatric surgery patients (Moize et al., 2003; Maïmoun et 
al., 2017; Coen et al., 2015). These studies have clearly supported the notion that when 
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post-bariatric patients adhere to a high protein diet their objectives of weight loss, for 
both clinical reasons and image issues, will achieve better results. Bariatric surgery, 
although an effective intervention, can only be sustainable the combination of healthy 
lifestyle including healthy eating (de Jong&Hinnen,2017; Herring et al., 2017). These 
patients need to be reminded that lifestyle factors and behavioral issues might have 
contributed largely to their excess weight over the years. They need to be reminded that 
although they have taken drastic measures to reduce weight to a healthy level, this can 
only be a start and the rest of the journey of weight loss and maintenance can only be 
done when a strong will is involved to make other changes, including eating habits and 
exercise.   
  
Our findings in regards to muscle and fat % change from baseline to 1 month 
follow-up, although not statically significant, are also consistent with a number of 
studies. When we look closely at these results we find that the intervention group muscle 
% (12.78) is healthier than that of the placebo group % (1.59), with a p value of the 
difference being 0.149,these results show trend towards significance. We think that these 
are positive findings given the trial period of 1 month and the sample size of our RCT. 
Perhaps with a longer period of follow up and a larger sample size the difference in 
muscle mass % between the intervention and the placebo groups could have been larger 
and more statistically significant. While these can be looked at as researchers or 
investigators conventions, there has been world-class reports that justified this point when 
  
   
58 
 
trials with short follow up were extended to longer follow up time the results were 
statistically significant or at least highly improved (Weerasooriya, 2011). 
 
Similar results to muscle mass % change were found for fat mass % change. Our 
study showed that after 1 month follow-up the change in fat % was +3.4 in the placebo 
group and -7.74 in the intervention group with a p value of 0.153. Once more, while the p 
value does not reflect statistical significance, we believe these are positive results from 
the perspectives of our study objectives. The intervention group have lost 7.74 % of their 
body fat while the placebo group, although they have lost fat in the form of total weight 
loss, their body fat % change has increased by 3.4%. The results in both groups can be 
partially explained by the loss and gain of muscle mass % which could have naturally 
affected the fat %. This is a great result, and similarly to our explanation of the statistical 
significance of the muscle mass % change, a longer follow-up period and a larger sample 
could have possibly pushed the p value of 0.153 to a more statistically significant value 
(i.e. ≤0.05).  
 
Studies looking at the effect of protein supplementation or protein rich diet in 
post-bariatric surgery patients have been consistent with our findings on the change in fat 
and muscle mass % (Moize et al., 2003; Bohl et al., 2015). Some of these studies with 
longer follow-up time than our trial have managed to show statistically significant results 
(Moldovan et al., 2016). However, there have been studies that also showed the lack of 
effect of protein rich diet or supplementations on changes in fat and muscle mass % (van 
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den Broek, 2016). 
 
Our study also found that albumin serum level but not total protein was enhanced 
by the protein supplementation. Our findings showed that the placebo group after 1 
month of follow-up gained 2.76% of albumin while the intervention group gained 9.71% 
of albumin over the same period with a p value of the difference of 0.031. These are 
definitely interesting, and at the same token, encouraging results, that the protein 
supplementation has had positive influence on albumin gain and maintenance but not the 
total protein. This is consistent with the science of muscle growth that mainly requires 
albumin (Visser et al., 2005).Our findings at the protein level and specifically albumin 
are consistent with other studies in this field (Schollenberger et al., 2016). The above 
study showed that protein supplementation after bariatric surgery improves body 
composition by enhancing loss of body fat mass and reducing loss of lean body mass 
within the 6 months follow up.  
 
We found no significant effect of the 1 month protein supplementation on the 
levels of Vit B12, Magnesium or Zinc. These results could be due to the short period of 
the trial. Perhaps these micronutrients can only start to show effect after a period of time. 
Studies on the effect of protein supplementations on the concentration of the above 
micronutrients and vitamins have shown conflicted results. In some studies they found 
that high rate of nutritional deficiencies is common after bariatric surgery with low 
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adherence to the nutritional supplementation regimen (Ben-Porat et al., 2017). Other 
study performed a prospective nutritional status evaluation before and at 2 and 5 years 
after SG in morbid obese patients receiving multivitamin and mineral supplementation 
found that about half of patients show some micronutrient deficiency at medium long 
term, despite supplementation (Pellitero et al., 2017; Mahawar, 2017; Alvarez-Leite, 
2004). 
 
As we mentioned earlier in this thesis, protein supplementation has been recently 
by HMC as a routine procedure for post-bariatric surgery patients. Our RCT is the first in 
Qatar to use scientific evidence to show the beneficial effect of protein supplementations 
on Qatari obese patients post bariatric surgery through a scientifically balanced 
assessment backed by a robust design of double-blinded randomized controlled trials that 
is considered top of the list of the hierarchy of scientific and epidemiological evidence. 
Our findings provide an additional support to the use of these supplements as part of the 
post-bariatric surgery dietary protocol.  
 
The uniqueness of our study is that we have looked at a distinctive population 
(Qatari obese patients), where a number of factors differ from subjects within the same 
category in the United States or other western countries. The environment in Qatar and 
the culture of Qatar society is influenced by a variety of traditional and context specific 
dynamics. Therefore, it is essential to show the effect of protein rich diet in post-bariatric 
patients in this specific setting so findings can apply to the context in Qatar. The primary 
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objectives of our study were to show the impact of protein supplementation on body 
composition in obese Qatari patients post bariatric surgery. We have done this through 
one of the highest level of evidence using a double-blinded randomized controlled trial.   
 
LIMITATION 
 Our study has a number of limitations. Firstly, the placebo group was given a 
solution that had 100 calories while the intervention group was given 250 calories. If 
anything, the intervention group will be disadvantaged by having those extra calories in 
their supplements. Also, the researchers did not objectively monitor the use of the 
treatment and therefore compliance may have been an issue here. It was practically 
impossible to determine the exact amount of protein (or placebo) that the participants 
have taken over the trial period. However, all attempts were made to follow up 
participants with phone calls to ensure compliance (data based on these phone calls were 
recorded and 80% of compliance was determined). The purpose of these phone calls was 
to ensure compliance in taking the supplements. A further limitation was the lack of 
information on diet. If participants had different diet regimen, then it is likely that this 
may have affected the results. However, it is well known that bariatric surgery patients 
generally adhere to liquid diet provided by the healthcare provider (or a dietitian) and it is 
almost impossible for them at this early stage to ingest any solid foods outside the easily 
digestible and recommended. 
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Another limitation is the fact that we included participants who have undergone 2 
types of bariatric surgery. This may have potentially affected the outcome. However,a 
recent study done on approximately 1000 post-bariatric patients has shown that no 
significant differences have been noted in weight loss and other parameters following 
different types of bariatric surgeries before one year (Pham et al., 2014).  
  
 
  
  
   
63 
 
13. CONCLUSION  
 
Obesity continues to be a major risk factor for a large slice of the population and 
for the majority of lifestyle NCDs. This highlights the importance of weight loss 
treatments and intervention, both surgical and non-surgical. High protein diet post-
bariatric surgery is a simple non-invasive intervention. Our study has confirmed findings 
from other recent studies that protein supplementation in post-bariatric surgery patients, 
who finds it extremely unpleasant to digest normal foods, is an effective intervention to 
improve weight loss. We have also found after 1 month of follow up that patients who 
took the treatment displayed higher level of serum albumin than those who took dietary 
advice alone. We have also shown trends towards significance in results of muscle and 
fat % change between the 2 groups. Our findings confirm previous research findings that 
meal replacement and liquid high protein diets can possibly put an end to “food craving” 
which is a process involved in crafting obesity in the first place. If food craving is not 
controlled, surgery alone cannot possibly provide a magical solution to obese individuals. 
This is very important and it must be well communicated with patients prior and 
following bariatric surgery. Patient education nowadays is a large part of treatment and 
prevention and healthcare providers, in this instance, must be more committed than ever 
to informing their patients of how they are expected to behave to ensure sustainability of 
weight loss.  
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14. RECOMMENDATIONS  
 
While surgery to reduce weight should be only performed in situations where the 
tertiary care needs are absolutely met for severely obese patients, we can say, based on 
our randomized clinical trial that bariatric surgery in combination with protein 
supplementation seems to be an effective method of weight reduction without loss of 
protein and muscle mass. It is also effective in reducing total fat %, which has been 
linked to a number of non-communicable diseases (as mentioned in our literature 
review). Our research suggests that bariatric surgery should be associated with high 
protein diet where all efforts are made to ensure compliance for optimal outcomes. This 
should be clearly explained to patients prior and post-surgery and patients should be 
convinced that the effectiveness of the surgical intervention may rely on this. We also 
recommend that adherence to high protein diet (fluid at early stages) is to be part of 
patient education in post-bariatric surgery care. The effectiveness of this can be accessed 
via means of follow-ups that include various methods of testing. After all, these 
approaches are designed to help patients achieve their goals in reducing their weight and 
keeping it off. We also recommend rather strongly that although bariatric surgery 
combined with high protein diet is an effective solution to obesity, healthy lifestyle and 
behavior stay the most crucial factor in living healthy and keeping the weight off. 
Healthy eating and exercise not only help reduce weight and keep it off, they are also 
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essential factors in cardiovascular health, mental health and many other health 
improvements. We recommend that once the body weight of post-bariatric patients has 
reached a moderate level (i.e. overweight replacing obese or morbidly obese), patients 
need to enroll in regular physical activity and upgrade their eating habits to healthier 
alternatives.  
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